Pfizer and Valneva's Lyme disease vaccine candidate marketing authorization application validated by European Medicines Agency

PFE•2026-08-14

EMA validates vaccine application

Aug. 14 (Reuters) - Pfizer and Valneva said their Lyme disease vaccine candidate marketing authorization application has been validated by the European Medicines Agency.

Pfizer and Valneva's Lyme disease vaccine candidate marketing authorization application validated by European Medicines Agency

EMA validates vaccine application

Related News

Swedish builder Skanska signs $957 million contract to build light rail transit in California

Block, Inc.: Canaccord Genuity raises target price to $100 from $85

Heico Corporation <HEI.N>: Jefferies Raises Target Price to $425 From $410

Chinese humanoid robot maker Unitree powers up for stellar Shanghai debut

ROI-Smart tugs and trucks that don't sleep. Automation rewires U.S. transport: Maguire